Education
About Us
Working with TipRanks
Follow Us
Qlife Holding AB (DE:4HG0)
FRANKFURT:4HG0
4HG0 Stock Chart & Stats
€0.25
-€0.01(-8.07%)
At close: 4:00 PM EST
€0.25
-€0.01(-8.07%)
Day’s Range― - ―
52-Week Range€0.09 - €0.43
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€2.77M
Enterprise Value€39.24M
Total Cash (Recent Filing)€2.81M
Total Debt (Recent Filing)€8.55M
Price to Earnings (P/E)―
Beta8.87
Next Earnings
Feb 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding12,484,911
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.76
Price to Book (P/B)-911.64
Price to Sales (P/S)26054.69
P/FCF Ratio-24.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
4HG0 FAQ
What was Qlife Holding AB’s price range in the past 12 months?
Qlife Holding AB lowest stock price was €0.09 and its highest was €0.43 in the past 12 months.
What is Qlife Holding AB’s market cap?
Qlife Holding AB’s market cap is €2.77M.
When is Qlife Holding AB’s upcoming earnings report date?
Qlife Holding AB’s upcoming earnings report date is Feb 11, 2026 which is in 47 days.
How were Qlife Holding AB’s earnings last quarter?
Qlife Holding AB released its earnings results on Nov 12, 2025. The company reported -€0.067 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.067.
Is Qlife Holding AB overvalued?
According to Wall Street analysts Qlife Holding AB’s price is currently Overvalued.
Does Qlife Holding AB pay dividends?
Qlife Holding AB does not currently pay dividends.
What is Qlife Holding AB’s EPS estimate?
Qlife Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Qlife Holding AB have?
Qlife Holding AB has 12,484,911 shares outstanding.
What happened to Qlife Holding AB’s price movement after its last earnings report?
Qlife Holding AB reported an EPS of -€0.067 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.882%.
Which hedge fund is a major shareholder of Qlife Holding AB?
Currently, no hedge funds are holding shares in DE:4HG0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Qlife Holding AB
Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents. The company offers Egoo.Health Platform, an integrated platform with a measuring instrument with disposable capsules and software, where each capsule contains a test for a specific biomarker or virus. Its biomarkers include C-reactive protein home-testing capsule, PHE/Phenylalanine for PKU patients, and Sars-CoV-2/Influenza multiplex for virus/bacteria tests. The company was incorporated in 2019 and is based in Helsingborg, Sweden.
Technical Analysis
SpectraCure AB
―
Luxbright AB
―
Scandinavian Real Heart AB
―
ScandiDos AB
―
Chordate Medical Holding AB
―